Tenon Medical (NASDAQ:TNON) Price Target Cut to $8.00 by Analysts at Maxim Group

Tenon Medical (NASDAQ:TNON) had its price target trimmed by Maxim Group from $22.00 to $8.00 in a report issued on Friday,Benzinga reports. The firm currently has a buy rating on the stock.

Separately, Benchmark reiterated a “speculative buy” rating and set a $3.00 price objective on shares of Tenon Medical in a research note on Wednesday, August 14th.

Tenon Medical Trading Down 3.6 %

Tenon Medical stock opened at $2.71 on Friday. The firm has a 50 day simple moving average of $4.05 and a 200 day simple moving average of $1.87. Tenon Medical has a 1-year low of $2.61 and a 1-year high of $22.32. The firm has a market capitalization of $1.38 million, a price-to-earnings ratio of -0.10 and a beta of 2.15.

About Tenon Medical

Tenon Medical, Inc, a medical device company, engages in the development of surgical implant systems to treat severe lower back pain in the United States and Puerto Rico. The company offers CATAMARAN SI-Joint Fusion System to fuse sacroiliac joints (SI-Joints) to treat SI-Joint dysfunction that often causes severe lower back pain; and features fixation device that passes through the axial and sagittal planes of the ilium and sacrum, as well as transfixes the SI joints.